Development

Articles

TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles. 

TFF Pharmaceuticals and Catalent Announce Development and Manufacturing Agreement

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.

Successfully Accelerating Formulation Strategies

Stevanato Group has extended its licensing agreement with Haselmeier for its Axis-D pen injector technology.

Stevanato Group, Haselmeier Extend Licensing Agreement for Pen Injector Technology

Cheryl Barton is director of PharmaVision, 

DTx manufacturers are taking advantage of the new regulatory flexibility, afforded by the COVID-19 pandemic, to pilot new products and generate real-world evidence to support regulatory filing and reimbursement.

Regulating Digital Therapeutics

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

SEDDS and SMEDDS improve solubility and permeability while expanding efficacy and applicability.

Lipids for Self-Emulsifying Drug Delivery Systems

The organizers of Pharmapack Europe have released the results of its global drug delivery and packaging survey, demonstrating the continuation of the United States’ lead in innovation.

US Leads the Way for Drug Device Innovation but Lags Behind for Sustainability, Notes Pharmapack 2021 Report

BioMed X has partnered with Janssen to start two new research programs for autoimmune diseases and drug delivery.

BioMed X and Janssen Start Up Research Programs in Autoimmunity and Drug Delivery

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

BioMed X Institute and Janssen Research & Development to start two new research programs in the field of autoimmune diseases and drug delivery.

Janssen Collaborates with BioMedX in Autoimmunity and Drug Delivery Research

Deanna Mudie, PhD, is principal scientist, Lonza, Bend, OR, USA.

Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.